BCR and neoplasm: Together, these results suggest that higher absolute counts of Vδ1 and Vδ2 T cells found in patients with higher levels of tumor burden and BCR::ABL1 reflects the ongoing expansion of γδ T lymphocytes mediating antileukemic responses.